Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lipoprotein(a) and Low-Molecular-Weight Apo(a) Phenotype as Determinants of New Cardiovascular Events in Patients with Premature Coronary Heart Disease

18 Oct 2023

Abstract excerpt

BACKGROUND: Lipoprotein(a) (Lp(a)) is a genetic risk factor of atherosclerotic cardiovascular diseases (ASCVDs). Proprotein convertase subtilisin/kexin type 9 (PCSK9) is related to vascular inflammation and detected in atherosclerotic plaques. A temporary increase in the circulating concentration of PCSK9 and Lp(a) was shown in patients with myocardial infarction (MI). The aim of this study was to evaluate the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atherosclerosis and Cardiovascular Diseases
Share to Lipoproteins and Cardiovascular Health
Share to Protease and Inhibitor Mechanisms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37873789
DOI: 10.3390/diseases11040145

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 20 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lipoprotein(a) and Low-Molecular-Weight Apo(a) Phenotype as Determinants of New Cardiovascular Events in Patients with Premature Coronary Heart DiseasePMID 37873789Read ↗

Lipoprotein(a): Bridging the Gap Between Screening and Treatment—A Narrative ReviewSemantic proximity Read ↗

Lipoprotein(a) as a Risk Factor for Cardiovascular Diseases: Pathophysiology and Treatment PerspectivesSemantic proximity Read ↗

Lipoprotein(a): a genetic marker for cardiovascular disease and target for emerging therapiesSemantic proximity Read ↗

Lipoprotein(a) and Traditional Risk Factors as Predictors of Premature Coronary Artery Disease: A Single-Center Retrospective StudySemantic proximity Read ↗

The different relations of PCSK9 and Lp(a) to the presence and severity of atherosclerotic lesions in patients with familial hypercholesterolemia.Semantic proximity Read ↗

Lipoprotein(a). A genetic risk factor for premature coronary heart diseaseSemantic proximity Read ↗

Clinical Relevance of Lipoprotein(a) in Young Acute Myocardial Infarction: STEMI vs. NSTEMISemantic proximity Read ↗

Extreme lipoprotein(a) levels and improved cardiovascular risk prediction.Semantic proximity Read ↗

Association of Lipoprotein(a) With SYNTAX Score in Young Adults Presenting with Acute Coronary Syndrome: A Cross-Sectional StudySemantic proximity Read ↗

Lipoprotein(a) and coronary heart disease.Semantic proximity Read ↗

Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age.Semantic proximity Read ↗

Platelet-activating factor-acetylhydrolase A379V (exon 11) gene polymorphism is an independent and functional risk factor for premature myocardial infarction.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.